IP Library Granted Patent US 8,841,437
Granted Patent B2
US 8,841,437 · App. 12/802,084 · Granted Sep 23, 2014

Precursor miRNA loop-modulated target regulation

Inventors: Chang-Zheng Chen (Stanford, CA); Robin Trujillo (Mountain View, CA); Sibiao Yue (Palo Alto, CA)
Assignee: The Board of Trustees of the Leland Stanford Junior University
C12N5/0636C12Q1/6811C12N2506/11C12N15/111C12N2310/141C12N2510/00C12N2501/42C12N2501/515
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,841,437
App. No.
12/802,084
Granted
Sep 23, 2014
Kind
B2
Abstract

Modulation of mRNA activity is achieved with precursor miRNAs (ta-RNAs). ta-RNAs, primarily pre-miRNAs and pri-miRNAs, including truncated and mutated ta-RNAs, are employed for modulation of mRNA expression where it is found that pri- and pre-miRNA have activity independently of the presence of functional mature miRNAs. Modification of at least one of the stem and loop of the ta-RNAs to enhance binding of the ta-RNA to the target mRNA is employed. The modification may be enhanced complementarity between the ta-RNA and the target mRNA and/or improved thermodynamic efficiency in binding of the ta-RNA to the target.

Claims (8)

1. A composition comprising:

a mutated precursor miRNA that hybridizes to a separate target mRNA, wherein said mutated precursor miRNA is from a wild-type precursor miRNA that hybridizes with said separate target mRNA sequence and which has an wild-type terminal loop comprising a wild-type terminal loop sequence, and

wherein said mutated precursor miRNA comprises a stem sequence and a terminal loop, wherein said terminal loop comprises a mutated terminal loop sequence with the same length as said wild-type terminal loop sequence,

wherein at least the first and second nucleotides, and/or the seventh and eighth nucleotides, counting from the 5′ end of said mutated terminal loop sequence, are substituted to enhance or reduce activity of said mutated precursor miRNA in binding and repressing said target mRNA sequence as compared to said wild-type precursor miRNA.

2. The composition of claim 1 , further comprising said separate target mRNA sequence.

3. The composition of claim 1 , wherein said mutated terminal loop sequence comprises at least 8 nucleotides, and wherein said at least 8 nucleotides are numbered from the 5′ end of said loop sequence as follows: position 1, position 2, position 3, position 4, position 5, position 6, position 7, and position 8.

4. The composition of claim 3 , wherein at least said positions 1 and 2 of said mutated terminal loop are substituted compared to said wild-type terminal loop.

5. The composition of claim 3 , wherein at least positions 7 and 8 of said mutated terminal loop are substituted compared to said wild-type terminal loop.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2010
From: CHEN, CHANG-ZHENG; TRUJILLO, ROBIN; YUE, SIBIAO
To: BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, THE
Reel/Frame 024851/0226 →
Continuity (3)
Continuation In Part 12214793 · Jun 20, 2008
Provisional Application 61271615 · Jul 23, 2009
Related Publication 20110020816A1 · Jan 27, 2011